Lung Cancer Biomarker Testing

Lung cancer biomarker testing—sometimes referred to as tumor, molecular, or genomic testing—looks for changes in the tumor's DNA.

You can think of your DNA like words in a book. When something goes wrong, the words can have typos which leads to the words in the book meaning something different. In the case of lung cancer, these changes to the “words” can lead to uncontrolled cell growth and cancer. Some lung cancer treatments can "target" these changes directly. These lung cancer treatments often cause fewer side effects because they focus on targeting what is exactly wrong with the cancer cell, instead of killing normal, healthy cells too. 

Key Facts

  • Biomarker testing looks for mutations, additions, deletions, or rearrangements in DNA.
  • Biomarker testing can also help look for other key markers like levels of certain proteins or the amount of tumor DNA in the blood.
  • Knowing this information can help influence treatment options.

Experts Explain Biomarker Testing

Frequently Asked Questions

Read common questions and answers you may have as you consider biomarker testing.
View FAQ

Navigating Biomarker Testing Checklist

Comprehensive biomarker testing is an important part of your treatment journey. See actions to take as you navigate your care.
Get checklist

Types of Lung Cancer Biomarkers

Lung cancer research can move at a rapid pace. Always speak with your doctor about the most up-to-date treatment guidelines.

  • Caring About Your Loved One with Lung Cancer Means Caring About Biomarker Testing

    Download

Page last updated: May 14, 2026

Community Connections: Lung Cancer: Challenges in Molecular Testing
, | May 26, 2026
Tobacco Basics
, | Jun 24, 2026